These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

953 related items for PubMed ID: 26921743

  • 1. Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.
    Koskinas KC, Zaugg S, Yamaji K, García-García HM, Taniwaki M, Klingenberg R, Moschovitis A, Lüscher TF, van Tits LJ, Matter CM, Windecker S, Räber L.
    Atherosclerosis; 2016 Apr; 247():154-60. PubMed ID: 26921743
    [Abstract] [Full Text] [Related]

  • 2. Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN.
    Puri R, Libby P, Nissen SE, Wolski K, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Raichlen JS, Uno K, Kataoka Y, Tuzcu EM, Nicholls SJ.
    Eur Heart J Cardiovasc Imaging; 2014 Apr; 15(4):380-8. PubMed ID: 24448227
    [Abstract] [Full Text] [Related]

  • 3. Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study.
    Räber L, Taniwaki M, Zaugg S, Kelbæk H, Roffi M, Holmvang L, Noble S, Pedrazzini G, Moschovitis A, Lüscher TF, Matter CM, Serruys PW, Jüni P, Garcia-Garcia HM, Windecker S, IBIS 4 (Integrated Biomarkers and Imaging Study-4) Trial Investigators (NCT00962416).
    Eur Heart J; 2015 Feb 21; 36(8):490-500. PubMed ID: 25182248
    [Abstract] [Full Text] [Related]

  • 4. Relationship Between Serum Inflammatory Marker Levels and the Dynamic Changes in Coronary Plaque Characteristics After Statin Therapy.
    Kwon O, Kang SJ, Kang SH, Lee PH, Yun SC, Ahn JM, Park DW, Lee SW, Kim YH, Lee CW, Han KH, Park SW, Park SJ.
    Circ Cardiovasc Imaging; 2017 Jul 21; 10(7):. PubMed ID: 28679524
    [Abstract] [Full Text] [Related]

  • 5. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
    Puri R, Nissen SE, Shao M, Kataoka Y, Uno K, Kapadia SR, Tuzcu EM, Nicholls SJ.
    Eur J Prev Cardiol; 2016 Mar 21; 23(5):474-85. PubMed ID: 25691546
    [Abstract] [Full Text] [Related]

  • 6. Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound.
    Nasu K, Tsuchikane E, Katoh O, Tanaka N, Kimura M, Ehara M, Kinoshita Y, Matsubara T, Matsuo H, Asakura K, Asakura Y, Terashima M, Takayama T, Honye J, Hirayama A, Saito S, Suzuki T.
    JACC Cardiovasc Interv; 2009 Jul 21; 2(7):689-96. PubMed ID: 19628194
    [Abstract] [Full Text] [Related]

  • 7. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
    Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM, ASTEROID Investigators.
    JAMA; 2006 Apr 05; 295(13):1556-65. PubMed ID: 16533939
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Time course of statin-induced changes in coronary atherosclerosis using intravascular ultrasound with virtual histology.
    Nozue T, Fukui K, Yamamoto S, Kunishima T, Umezawa S, Onishi Y, Tohyama S, Hibi K, Sozu T, Terashima M, Michishita I, TRUTH Investigators.
    Coron Artery Dis; 2013 Sep 05; 24(6):481-6. PubMed ID: 23751736
    [Abstract] [Full Text] [Related]

  • 12. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.
    Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J, Orazem J, Magorien RD, O'Shaughnessy C, Ganz P, Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Investigators.
    N Engl J Med; 2005 Jan 06; 352(1):29-38. PubMed ID: 15635110
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy.
    Puri R, Nissen SE, Libby P, Shao M, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Raichlen JS, Uno K, Kataoka Y, Nicholls SJ.
    Circulation; 2013 Nov 26; 128(22):2395-403. PubMed ID: 24043299
    [Abstract] [Full Text] [Related]

  • 15. The effect of lipid and inflammatory profiles on the morphological changes of lipid-rich plaques in patients with non-ST-segment elevated acute coronary syndrome: follow-up study by optical coherence tomography and intravascular ultrasound.
    Takarada S, Imanishi T, Ishibashi K, Tanimoto T, Komukai K, Ino Y, Kitabata H, Kubo T, Tanaka A, Kimura K, Mizukoshi M, Akasaka T.
    JACC Cardiovasc Interv; 2010 Jul 26; 3(7):766-72. PubMed ID: 20650439
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
    Aydin MU, Aygul N, Altunkeser BB, Unlu A, Taner A.
    Atherosclerosis; 2015 Apr 26; 239(2):439-43. PubMed ID: 25697576
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of statin therapy on the progression of coronary atherosclerosis.
    Tian J, Gu X, Sun Y, Ban X, Xiao Y, Hu S, Yu B.
    BMC Cardiovasc Disord; 2012 Sep 01; 12():70. PubMed ID: 22938176
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.